Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: insights from

Rajendra H Mehta1, Vincent J Bufalino, Wenqin Pan

  • 1Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA.

Insights

Door-to-balloon times for ST-elevation myocardial infarction patients improved but remain suboptimal. Delays persist for elderly, women, and minority patients, highlighting the need for quality improvement initiatives.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement
  • Public Health

Background:

  • Door-to-balloon (D2B) time is a critical metric for ST-elevation myocardial infarction (STEMI) reperfusion therapy.
  • The target D2B time is ideally less than or equal to 90 minutes.
  • Consistency of achieving D2B goals in real-world practice, especially for vulnerable populations, is not well understood.

Purpose of the Study:

  • To evaluate the trends and disparities in D2B times for STEMI patients undergoing primary percutaneous coronary intervention (PCI).
  • To assess D2B time performance across different patient demographics, including age, sex, and race/ethnicity.
  • To identify persistent gaps in care and inform quality improvement efforts.

Main Methods:

  • Utilized the American Heart Association Get With the Guidelines database (2002-2006) including 254 US sites.
  • Analyzed median D2B times and the percentage of patients achieving D2B ≤90 minutes.
  • Employed generalized estimating equations to assess trends over time and disparities among patient subgroups (elderly, women, minorities).

Main Results:

  • A total of 10,965 STEMI patients receiving primary PCI were analyzed.
  • Overall median D2B time was 96 minutes, with only 44.8% of patients meeting the ≤90 minute goal.
  • While D2B times improved significantly over the study period (from 108 to 82 minutes), elderly patients, women, and minorities consistently experienced longer D2B times, with these disparities persisting.

Conclusions:

  • Median D2B times for STEMI patients have modestly improved but remain below the recommended 90-minute goal.
  • Significant and persistent delays in D2B times were observed in elderly, female, and minority patient populations.
  • Continued national quality improvement initiatives are essential to address these disparities and optimize STEMI care.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...